Dermata Therapeutics, Inc. (DRMA) SEC Filings https://ir.dermatarx.com/sec-filings/all-sec-filings/rss Dermata Therapeutics, Inc. (DRMA) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/dermatarx/files/theme/images/logo-sm.png Dermata Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-015348/0001493152-26-015348.pdf Tue, 07 Apr 26 06:02:03 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-015348/0001493152-26-015348.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012992/0001493152-26-012992.pdf Thu, 26 Mar 26 17:21:59 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012992/0001493152-26-012992.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012991/0001493152-26-012991.pdf Thu, 26 Mar 26 17:17:29 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012991/0001493152-26-012991.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-010630/0001493152-26-010630.pdf Tue, 17 Mar 26 17:44:47 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-010630/0001493152-26-010630.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-008037/0001493152-26-008037.pdf Wed, 25 Feb 26 16:10:03 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-008037/0001493152-26-008037.pdf <![CDATA[SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-007792/0001493152-26-007792.pdf Mon, 23 Feb 26 19:56:49 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-007792/0001493152-26-007792.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001172661-26-001308/0001172661-26-001308.pdf Wed, 18 Feb 26 16:50:11 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001172661-26-001308/0001172661-26-001308.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001172661-26-001248/0001172661-26-001248.pdf Tue, 17 Feb 26 21:48:23 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001172661-26-001248/0001172661-26-001248.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-000261/0000921895-26-000261.pdf Mon, 09 Feb 26 17:45:32 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-000261/0000921895-26-000261.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-004905/0001493152-26-004905.pdf Tue, 03 Feb 26 16:07:07 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-004905/0001493152-26-004905.pdf